Neurosense Therapeutics Ltd (NRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRSN | BMY | AMGN | GILD | GSK |
| Company | Neurosense Therapeutics Ltd | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.3900 | 49.89 | 337.03 | 84.39 | 42.40 |
| High | 1.3900 | 50.04 | 338.70 | 84.65 | 42.42 |
| Low | 1.3200 | 49.11 | 334.61 | 83.57 | 41.46 |
| Last | 1.3500 | 49.44 | 337.27 | 84.49 | 41.78 |
| Change | unch | -0.30 | +4.35 | +0.60 | -0.65 |
| % Change | unch | -0.60% | +1.31% | +0.72% | -1.53% |
| Volume | 37,840 | 3,074,769 | 613,278 | 3,507,688 | 3,983,716 |
| 20-Day Average Volume | 403,025 | 8,313,873 | 1,708,644 | 6,418,723 | 3,617,577 |
| Previous Close | 1.3500 | 49.74 | 332.92 | 83.89 | 42.43 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0460 | 49.11 | 329.63 | 80.10 | 43.28 |
| 20-Day Raw Stochastic | 86.57% | 63.63% | 89.40% | 95.28% | 11.87% |
| 20-Day Relative Strength | 72.36% | 55.66% | 58.35% | 72.89% | 47.98% |
| Weighted Alpha | -10.79 | -10.39 | +27.58 | +19.29 | +10.86 |
| Today's Opinion | 24% Buy | 72% Buy | 96% Buy | 88% Buy | 48% Buy |
| Previous Opinion | 24% Buy | 72% Buy | 88% Buy | 88% Buy | 56% Buy |
| Last Month's Opinion | 72% Sell | 40% Buy | 88% Buy | 56% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.65% since 09/12/24 | +2.29% since 09/12/24 | +2.07% since 09/12/24 | +1.54% since 09/12/24 | -2.92% since 09/12/24 |
| Low | 1.1900 on 09/13/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 41.47 on 09/19/24 |
| High | 1.4550 on 09/16/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 43.62 on 09/16/24 |
| 1-Month | |||||
| %Chg | +76.24% since 08/19/24 | +0.09% since 08/19/24 | +2.72% since 08/19/24 | +13.42% since 08/19/24 | +0.79% since 08/19/24 |
| Low | 0.6729 on 08/28/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 41.47 on 09/19/24 |
| High | 1.4550 on 09/16/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 44.67 on 08/27/24 |
| 3-Month | |||||
| %Chg | +46.74% since 06/18/24 | +20.91% since 06/18/24 | +10.10% since 06/18/24 | +33.71% since 06/18/24 | +2.20% since 06/18/24 |
| Low | 0.5120 on 07/19/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 37.81 on 07/02/24 |
| High | 1.5000 on 07/02/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 44.67 on 08/27/24 |
| 6-Month | |||||
| %Chg | -8.78% since 03/19/24 | -4.74% since 03/19/24 | +23.98% since 03/19/24 | +15.03% since 03/19/24 | -1.11% since 03/19/24 |
| Low | 0.5120 on 07/19/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 37.81 on 07/02/24 |
| High | 2.2500 on 04/04/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,449 | 100,827,960 | 178,589,936 | 104,514,608 | 87,935,408 |
| Shares Outstanding, K | 13,666 | 2,027,100 | 536,435 | 1,245,853 | 2,072,482 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 37,725,000,000 |
| Annual Net Income | -11,280,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 9,950,400,000 |
| Last Quarter Net Income | -5,400,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,480,440,000 |
| 60-Month Beta | 1.52 | 0.46 | 0.61 | 0.18 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 06/24/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 1.09 on 07/31/24 |
| Latest Earnings Date | 09/18/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/06/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | 0.378 on 08/16/24 |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | 08/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 17.67 | 10.23 |